文献速递妇科

机器人辅助与开腹根治性子宫切除术治疗宫颈癌的多中心回顾性比较

Comparison between robot-assisted radical hysterectomy and abdominal radical hysterectomy for cervical cancer: A multicentre retrospective study.
PubMed 文献 · Gynecol Oncol · 2020-02-15

该多中心回顾性研究纳入10314例FIGO IA1(伴LVSI)至IIA2期宫颈癌患者,比较机器人辅助根治性子宫切除术(RRH,n=1048)与开腹根治性子宫切除术(ARH,n=9266)的3年肿瘤学结局。总体RRH与ARH的3年OS和DFS率相似,但多因素分析显示RRH与较低的3年DFS率相关;倾向性评分匹配后RRH的3年OS和DFS率均低于ARH。在IB1期且肿瘤<2cm患者中,RRH与ARH的3年OS和DFS率无显著差异。

要点

  • 总体RRH与ARH的3年OS和DFS率相似,但匹配后RRH的3年OS和DFS率均低于ARH。
  • 多因素分析显示RRH与较低的3年DFS率相关(HR 1.20,95%CI 1.09-1.52,p=0.035)。
  • IB1期且肿瘤<2cm患者中RRH与ARH的3年OS和DFS率无显著差异。

核心结论

  • 在FIGO IA1(伴LVSI)至IIA2期宫颈癌患者中,总体RRH的3年肿瘤学结局劣于ARH。
  • 在IB1期且肿瘤<2cm患者中,RRH与ARH的3年肿瘤学结局相似。

研究设计与样本

  • 多中心回顾性研究,纳入10314例宫颈癌患者,RRH组1048例,ARH组9266例,分期为IA1(伴LVSI)至IIA2期。
  • 采用Kaplan-Meier生存分析和log-rank检验比较3年OS和DFS率,Cox比例风险模型和倾向性评分匹配估计手术方式特异性生存。

主要发现

  • RRH与ARH的3年OS和DFS率相似(93.5% vs. 94.1%,p=0.486;90.0% vs. 90.4%,p=0.302)。
  • 多因素分析显示RRH与较低的3年DFS率相关(HR 1.20,95%CI 1.09-1.52,p=0.035),与3年OS率无关(HR 1.23,95%CI 0.89-1.70,p=0.206)。
  • 倾向性评分匹配后,RRH组3年OS和DFS率低于ARH组(94.4% vs. 97.8%,p=0.002;91.1% vs. 95.4%,p=0.001)。
  • IB1期且肿瘤<2cm患者中,RRH与ARH的3年OS和DFS率无显著差异(HR 1.688,95%CI 0.423-6.734,p=0.458;HR 1.267,95%CI 0.518-3.098,p=0.604)。

临床怎么用

  • 对于FIGO IA1(伴LVSI)至IIA2期宫颈癌患者,选择RRH需权衡其可能较差的3年肿瘤学结局。
  • 对于IB1期且肿瘤<2cm患者,RRH可作为与ARH肿瘤学结局相似的选项。

局限性

  • 回顾性研究设计可能存在选择偏倚。
  • 倾向性评分匹配后样本量减少可能影响统计效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare 3-year overall survival (OS) and disease-free survival (DFS) rates of robot-assisted radical hysterectomy (RRH) and abdominal radical hysterectomy (ARH) for cervical cancer. METHODS: We retrospectively compared the oncological outcomes of 10,314 cervical cancer patients who received RRH (n = 1048) or ARH (n = 9266) and whose stages were IA1 with lymphovascular space invasion (LVSI)-IIA2. Kaplan-Meier survival analysis and log-rank tests were used to compare the 3-year OS and DFS rates between the RRH and ARH groups. Cox proportional hazards model and propensity score matching was used to estimate the surgical approach-specific survival. RESULTS: RRH and ARH showed similar 3-year OS and DFS rates (93.5% vs. 94.1%, p = 0.486; 90.0% vs. 90.4%, p = 0.302). RRH was not associated with a lower 3-year OS rate by the multivariable analysis (HR 1.23, 95% CI 0.89-1.70, p = 0.206), but it was associated with a lower 3-year DFS rate (HR 1.20, 95% CI 1.09-1.52, p = 0.035). After propensity score matching, patients who underwent RRH had decreased 3-year OS and DFS rates compared to those who underwent ARH (94.4% vs. 97.8%, p = 0.002; 91.1% vs. 95.4%, p = 0.001), and RRH was associated with lower 3-year OS and DFS rates. Among patients with stage IB1 and tumor size <2 cm, RRH was not associated with decreased 3-year OS and DFS rates (HR1.688, 95% CI 0.423-6.734, p = 0.458; HR1.267, 95%CI 0.518-3.098, p = 0.604). CONCLUSIONS: Overall, RRH was associated with worse 3-year oncological outcomes than ARH in patients with FIGO stage IA1 with LVSI- IIA2 cervical cancer. However, RRH showed similar 3-year oncological outcomes with ARH among those with stage IB1 and tumor size <2 cm.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Chen B, Ji M, Li P, et al. Comparison between robot-assisted radical hysterectomy and abdominal radical hysterectomy for cervical cancer: A multicentre retrospective study. Gynecol Oncol. 2020. PMID: 32067814. doi:10.1016/j.ygyno.2020.02.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。